Found: 119
Select item for more details and to access through your institution.
Building a better blinatumomab.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 512, doi. 10.1002/ajh.27253
- By:
- Publication type:
- Article
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 606, doi. 10.1002/ajh.27231
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
Momelotinib for myelofibrosis: 12‐year survival data and retrospective comparison to ruxolitinib.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E433, doi. 10.1002/ajh.26714
- By:
- Publication type:
- Article
A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
- By:
- Publication type:
- Article
Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E232, doi. 10.1002/ajh.26546
- By:
- Publication type:
- Article
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
- By:
- Publication type:
- Article
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 630, doi. 10.1002/ajh.26498
- By:
- Publication type:
- Article
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E138, doi. 10.1002/ajh.26464
- By:
- Publication type:
- Article
Outcomes of venetoclax‐based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E433, doi. 10.1002/ajh.26334
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
- By:
- Publication type:
- Article
Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
- By:
- Publication type:
- Article
A population‐based study of chronic eosinophilic leukemia‐not otherwise specified in the United States.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E257, doi. 10.1002/ajh.25906
- By:
- Publication type:
- Article
Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E68, doi. 10.1002/ajh.25729
- By:
- Publication type:
- Article
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 111, doi. 10.1002/ajh.25333
- By:
- Publication type:
- Article
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
- By:
- Publication type:
- Article
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. E398, doi. 10.1002/ajh.25287
- By:
- Publication type:
- Article
Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. 1074, doi. 10.1002/ajh.25162
- By:
- Publication type:
- Article
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E49, doi. 10.1002/ajh.24980
- By:
- Publication type:
- Article
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. E164, doi. 10.1002/ajh.24765
- By:
- Publication type:
- Article
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 308, doi. 10.1002/ajh.24265
- By:
- Publication type:
- Article
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 4, p. 283, doi. 10.1002/ajh.23388
- By:
- Publication type:
- Article
Long-term outcome of pomalidomide therapy in myelofibrosis.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 66, doi. 10.1002/ajh.22233
- By:
- Publication type:
- Article
A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
- By:
- Publication type:
- Article
Phase1/-2 study of Pomalidomide in myelofibrosis.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 2, p. 129, doi. 10.1002/ajh.21598
- By:
- Publication type:
- Article
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 8, p. 614, doi. 10.1002/ajh.21191
- By:
- Publication type:
- Article
Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab.
- Published in:
- ImmunoTargets & Therapy, 2014, v. 3, p. 79, doi. 10.2147/ITT.S37292
- By:
- Publication type:
- Article
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: Effect of specimen source (bone marrow or peripheral blood) on assay readouts.
- Published in:
- Cytometry. Part B, 2012, v. 82B, n. 3, p. 158, doi. 10.1002/cyto.b.21007
- By:
- Publication type:
- Article
Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 5, p. 384, doi. 10.3816/clm.2006.n.014
- By:
- Publication type:
- Article
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
- Published in:
- Acta Haematologica, 2016, v. 136, n. 4, p. 210, doi. 10.1159/000448160
- By:
- Publication type:
- Article
A systematic review of religious beliefs about major end-of-life issues in the five major world religions.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 1989, v. 32, n. 3, p. 226, doi. 10.1002/ajh.2830320313
- By:
- Publication type:
- Article
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
- Published in:
- Transplant Infectious Disease, 2016, v. 18, n. 6, p. 913, doi. 10.1111/tid.12612
- By:
- Publication type:
- Article
Pharmacotherapeutic Advances in the Treatment of Acute Lymphoblastic Leukaemia in Adults.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Pharmacotherapeutic Advances in the Treatment of Acute Lymphoblastic Leukaemia in Adults.
- Published in:
- Drugs, 2011, v. 71, n. 4, p. 415
- By:
- Publication type:
- Article
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Update on Transplant in ALL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S13, doi. 10.1016/j.clml.2017.08.011
- By:
- Publication type:
- Article
Nelarabine in Adult Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma(T-ALL/T-LBL): The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S253, doi. 10.1016/j.clml.2017.07.015
- By:
- Publication type:
- Article
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01028-4
- By:
- Publication type:
- Article
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01000-2
- By:
- Publication type:
- Article
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00908-5
- By:
- Publication type:
- Article
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
- By:
- Publication type:
- Article